Outcome and cost‐effectiveness of transdiagnostic cognitive behavioral therapy compared with management as usual for youth with common mental health problems: Long‐term results from the Mind‐My‐Mind randomized trial
Although MMM was potentially cost-effective, the beneficial effects diminished over 3 years post-treatment. The findings highlight the need for strategies to sustain long-term effects.
Authors
- Anne Katrine Pagsberg (ORCID: https://orcid.org/0000-0003-0818-8338)
- Mikael Thastum (ORCID: https://orcid.org/0000-0001-8582-5682)
- K. Plessen
- Sabrina Mai Nielsen (ORCID: https://orcid.org/0000-0003-2857-2484)
- N. Bilenberg
- Rasmus Trap Wolf (ORCID: https://orcid.org/0000-0002-0466-300X)
- Ditte Vassard (ORCID: https://orcid.org/0000-0001-6298-4146)
- Pia Jeppesen (ORCID: https://orcid.org/0000-0003-2471-2929)
- Per Hove Thomsen
- Robin Christensen
- Frank Verhulst
- Martin Køster Rimvall
- Christoph U Correll
- Simon-Peter Neumer
- Wendy K Silverman
Institutions
- University of Copenhagen (DK)
- Feinstein Institute for Medical Research (US)
- University of Southern Denmark (DK)
- Aarhus University (DK)
- Mental Health Services (DK)
- Frederiksberg Hospital (DK)
- Odense University Hospital (DK)
- Erasmus MC (NL)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Yale University (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- Psychiatry Region Zealand (DK)
- Region of Southern Denmark (DK)
- Center for Child and Adolescent Mental Health, Eastern and Southern Norway (NO)
- Zucker Hillside Hospital (US)
- Charité - Universitätsmedizin Berlin (DE)
- University of Lausanne (CH)
Publication Details
- Journal
- Journal of Child Psychology and Psychiatry
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1111/jcpp.70128
- Citations
- 1
- Primary Topic
- Child and Adolescent Psychosocial and Emotional Development
- Type
- article
- Field-Weighted Citation Impact
- 44.11
Funders
- Pfizer
- Patient-Centered Outcomes Research Institute
- Teva Pharmaceutical Industries
- Shire
- Aarhus Universitet
- Sunovion
- Indivior
- ACADIA Pharmaceuticals
- Parker Institute for Cancer Immunotherapy
- Neurocrine Biosciences
- Supernus Pharmaceuticals
- Mylan
- Gedeon Richter
- Lundbeckfonden
- Novo Nordisk
- Region Hovedstaden
- Angelini Pharma
- Otsuka Pharmaceutical
- TrygFonden
- Region Sjælland
- Region Midtjylland
- H. Lundbeck A/S
- Berlin Institute of Health
- Allergan
- National Institute of Mental Health